1. Academic Validation
  2. The adapter protein FADD provides an alternate pathway for entry into the cell cycle by regulating APC/C-Cdh1 E3 ubiquitin ligase activity

The adapter protein FADD provides an alternate pathway for entry into the cell cycle by regulating APC/C-Cdh1 E3 ubiquitin ligase activity

  • J Biol Chem. 2023 May 3;104786. doi: 10.1016/j.jbc.2023.104786.
Sahezeel Awadia 1 Merna Sitto 1 Sundaresh Ram 2 Wenbin Ji 1 Yajing Liu 1 Raheema Damani 3 Dipankar Ray 1 Theodore S Lawrence 1 Craig J Galban 2 Steven D Cappell 4 Alnawaz Rehemtulla 5
Affiliations

Affiliations

  • 1 University of Michigan Medical School, Department of Radiation Oncology, Ann Arbor, Michigan, USA.
  • 2 University of Michigan Medical School, Department of Radiology and Biomedical Engineering, Ann Arbor, Michigan, USA.
  • 3 University of Alabama at Birmingham, AL, USA.
  • 4 Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • 5 University of Michigan Medical School, Department of Radiation Oncology, Ann Arbor, Michigan, USA. Electronic address: alnawaz@umich.edu.
Abstract

The E3 ubiquitin Ligase APC/C-Cdh1 maintains the G0/G1 state, and its inactivation is required for cell cycle entry. We reveal a novel role for Fas-associated protein with death domain (FADD) in the cell cycle through its function as an inhibitor of APC/C-Cdh1. Using real-time, single-cell imaging of live cells combined with biochemical analysis, we demonstrate that APC/C-Cdh1 hyperactivity in FADD- deficient cells leads to a G1 arrest despite persistent mitogenic signaling through oncogenic EGFR/KRAS. We further show that FADDWT interacts with Cdh1, while a mutant lacking a consensus KEN-box motif (FADDKEN) fails to interact with Cdh1 and results in a G1 arrest due to it its inability to inhibit APC/C-Cdh1. Additionally, enhanced expression of FADDWT but not FADDKEN, in cells arrested in G1 upon CDK4/6 inhibition, leads to APC/C-Cdh1 inactivation and entry into the cell cycle in the absence of retinoblastoma protein (Rb)- phosphorylation. FADD's function in the cell cycle requires its phosphorylation by CK1α at Ser-194 which promotes its nuclear translocation. Overall, FADD provides a CDK4/6-Rb-E2F independent "bypass" mechanism for cell cycle entry and thus a therapeutic opportunity for CDK4/6 inhibitor resistance.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-50767
    99.94%, CDK4/6抑制剂
    CDK